Search Results 261-270 of 4349 for 搜索留痕技术咨询邮箱：lgooxc@hotmail.com

  1. Patient Stories - Aiming Lu, Ph.D. - Mayo Clinic

    Have 2X the impact! ... Make a gift that can go twice as far to advance healthcare research. Give Today.

  2. CME Disclosures - Training and Education - Center for Clinical and Translational Science (CCaTS)

    CME Disclosures. As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), Mayo Clinic College of Medicine and Science ...

  3. Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Capping - Methodist-Kahler School of Nursing Alumni Association - Alumni Center - Mayo Clinic College of Medicine & Science

    Three months after entry into the Kahler and Methodist-Kahler nursing programs, students received their caps during the capping ceremony. This traditionally ...

  5. Is Our Microbiome a Predictor of Cardiac Risk - Mayo Clinic

    The purpose of this study is to compare the fecal microbiota of patients with mild, moderate and severe Coronary Artery Disease (CAD) by collecting stool and ...

  6. Other Requirements - Center for Clinical and Translational Science

    This monthly forum provides you an opportunity to network, share program information and discuss your research project with other students. CTS Journal Club.

  7. Academics - Find a Program at Mayo Clinic College of Medicine & Science

    Type: Fellowship; Duration: 1-2 years; School: Graduate Medical Education; Specialty: Laboratory Medicine & Pathology ...

  8. Ophthalmology Physician Update e-Edition

    A triannual publication for physicians that discusses trends and advances in ophthalmology at Mayo Clinic.

  9. IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma - Mayo Clinic

    A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide ...